JOINN Biologics

JOINN Biologics is a premier CDMO offering end-to-end development and manufacturing services for complex biologics, including monoclonal antibodies, bispecifics, and ADCs. It differentiates itself through its integrated CRO-CDMO model with JOINN Labs, providing robust analytical, formulation, and IND-enabling PK/PD/TOX services under one quality system. Led by an experienced US-based management team with decades of big pharma expertise, the company targets biotech clients needing flexible, scientifically challenging program support from early development through cGMP manufacturing.

Integrated CRO-CDMO service platform for complex biologics, offering end-to-end capabilities from cell line development and process development to cGMP manufacturing and IND-enabling PK/PD/TOX studies, leveraging collaboration with sister CRO JOINN Labs.

JOINN Biologics competes in the crowded global biologics CDMO market against large players like Lonza, Catalent, and Fujifilm Diosynth, as well as numerous specialized and regional competitors. Its primary competitive differentiation is its integrated service offering with its sister CRO, JOINN Labs, and its focus on complex modalities with US-based leadership and operations.